Covetrus, Inc. (CVET) |
20.99 0 (0%) 10-12 16:00 |
Open: | 20.93 |
High: | 21 |
Low: | 20.93 |
Volume: | 5,300,387 |
Market Cap: | 0(M) |
PE Ratio: | -69.97 |
Exchange: | NASDAQ Global Select |
Industry: | Medical - Distribution |
Sector: | Healthcare |
Technical analysis | ||||
sell | buy |
Resistance 2: | 24.53 |
Resistance 1: | 21.00 |
Pivot price: | 20.99 |
Support 1: | 20.96 |
Support 2: | 20.93 |
52w High: | 21.2 |
52w Low: | 13.39 |
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions, such as inventory management and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software, data-driven applications, client communications tools, and related services to increase staff efficiency and enhance business health; and solutions that integrate with its software platforms, including client communication services, reminders, data backup services, hardware sales and support, and credit card processing services for veterinary practitioners and animal-health clinics. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as offers shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal, equine, and large-animal markets primarily in North America, Europe, and the Asia Pacific. The company was formerly known as HS Spinco, Inc. Covetrus, Inc. was incorporated in 2018 and is headquartered in Portland, Maine. As of October 13, 2022, Covetrus, Inc. was taken private.
EPS | -0.220 |
Book Value | 11.300 |
PEG Ratio | 1.62 |
Gross Profit | 6.227 |
Profit Margin (%) | -0.87 |
Operating Margin (%) | -0.22 |
Return on Assets (ttm) | -0.2 |
Return on Equity (ttm) | -2.6 |
Tue, 05 Jul 2022
COVETRUS, INC. INVESTIGATION REMINDER: Scott+Scott Attorneys at Law LLP Investigates Clayton, Dubilier & Rice ... - GlobeNewswire
Thu, 02 Jun 2022
Clayton, Dubilier & Rice/TPG Are Not Offering Fair Value To Covetrus Shareholders - Seeking Alpha
Wed, 25 May 2022
Covetrus to Be Taken Private for $4 Billion - Barron's
Wed, 25 May 2022
Covetrus to Be Acquired by CD&R and TPG | Clayton Dubilier & Rice, LLC - Clayton Dubilier & Rice, LLC
Wed, 25 May 2022
Covetrus to Be Acquired by Clayton, Dubilier & Rice and TPG at an Enterprise Valuation of Approximately $4 Billion - Business Wire
Fri, 20 May 2022
Is Covetrus Inc (CVET) a Stock to Watch After Gaining 33.27% This Week? - InvestorsObserver
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |